1. Pink Sheet
  2. >>Geography

EU Decision Time For GSK’s Rare Cancer Drug Momelotinib & Others

 
• By Eliza Slawther

The European Medicines Agency is this week due to decide whether to back pan-EU marketing authorization for seven products, including three for orphan indications.

• Source: Shutterstock

GSK could soon learn whether its orphan drug momelotinib, which it acquired as part of a $2bn buyout of Sierra Oncology, will be recommended for EU marketing approval by the European Medicines Agency.

Momelotinib, an oral treatment for the key manifestations of myelofibrosis, including anemia and splenomegaly, is among seven new products for which initial EU marketing authorization applications (MAAs) are listed as being up for an opinion on the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography

Inclusive By Design: UK Pilots Diversity Plans For Drug & Device Trials

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

UK’s International Recognition Procedure: EU Dossier Faster Than US Or Canada

 
• By Eliza Slawther

Companies that use the European Medicines Agency as a reference regulator for the UK’s International Recognition Procedure can expect a faster approval than those that use other national regulators, such as those in the US and Canada, an MHRA spokesperson has said.

FDA Use Of Artificial Intelligence Will Help US Retain Biotech Leadership

 
• By Sue Sutter and Derrick Gingery

At a House subcommittee hearing, HHS Secretary Robert F. Kennedy Jr. rebutted lawmaker concerns that NIH cuts will drive research and scientists to other countries and said he does not want to advise parents on vaccinating children for measles, chickenpox or polio.